Key Takeaways On April 1, 2026, FDA issued a statement reminding 503A pharmacies and 503B outsourcing facilities that ...
The reference architecture connects enterprise and public scientific data to accelerate target identification and compound ...
Introduction Skin rash is the most common adverse effect in patients with cancer receiving epidermal growth factor receptor inhibitors (EGFRIs), which can impair quality of life and lead to treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results